Search Results - Michael D. Prados

Refine Results
  1. 1
    Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

    Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis by Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

    Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors by Luís A. Rodríguez, Michael D. Prados, Pamela Silver, Victor A. Levin

    Published 1989
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Effect of disease burden on health-related quality of life in patients with malignant gliomas

    Effect of disease burden on health-related quality of life in patients with malignant gliomas by David Osoba, Michael Brada, Michael D. Prados, W.K. Alfred Yung

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Necrosis as a prognostic factor in glioblastoma multiforme

    Necrosis as a prognostic factor in glioblastoma multiforme by Fred G. Barker, Richard L. Davis, Susan M. Chang, Michael D. Prados

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity

    Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity by Seunggu J. Han, Isaac Yang, Tarık Tihan, Michael D. Prados, Andrew T. Parsa

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma

    18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma by Fred G. Barker, Susan M. Chang, Peter E. Valk, Thomas R. Pounds, Michael D. Prados

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine or PCV Adjuvant Chemotherapy

    Procarbazine, Lomustine, and Vincristine (PCV) Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With... by Michael D. Prados, Charles Scott, Walter J. Curran, Diana F. Nelson, Steve Leibel, Simon Krämer

    Published 1999
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing

    An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing by Yasuyuki Aoki, Rintaro Hashizume, Tomoko Ozawa, Anu Banerjee, Michael D. Prados, C. David James, Nalin Gupta

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area1

    Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area1 by Margaret Wrensch, Terri Rice, Rei Miike, Alex McMillan, Kathleen R. Lamborn, Kenneth Aldape, Michael D. Prados

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma

    Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma by Mei‐Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer Clarke, Michael D. Prados

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A human brainstem glioma xenograft model enabled for bioluminescence imaging

    A human brainstem glioma xenograft model enabled for bioluminescence imaging by Rintaro Hashizume, Tomoko Ozawa, Eduard B. Dinca, Anuradha Banerjee, Michael D. Prados, C. David James, Nalin Gupta

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Temozolomide in the treatment of recurrent malignant glioma

    Temozolomide in the treatment of recurrent malignant glioma by Susan M. Chang, Philip V. Theodosopoulos, Kathleen R. Lamborn, Mary Malec, Jane Rabbitt, Margaretta Page, Michael D. Prados

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype

    Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype by Patricia Goldhoff, Jennifer Clarke, Ivan Smirnov, Mitchel S. Berger, Michael D. Prados, C. David James, Arie Perry, Joanna J. Phillips

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

    A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy by Mark R. Gilbert, Henry S. Friedman, John F. Kuttesch, Michael D. Prados, Jeffrey J. Olson, Gregory H. Reaman, Sara Zaknoen

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma

    The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma by Seunggu J. Han, Caleb Rutledge, Annette M. Molinaro, Susan M. Chang, Jennifer Clarke, Michael D. Prados, Jennie Taylor, Mitchel S. Berger, Nicholas Butowski

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    High failure rate in spinal ependymomas with long-term follow-up

    High failure rate in spinal ependymomas with long-term follow-up by Daniel R. Gomez, Brian Missett, William M. Wara, Kathleen R. Lamborn, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Daphne A. Haas‐Kogan

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients

    Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients by Seunggu J. Han, Isaac Yang, Brian Ahn, José Javier Otero, Tarık Tihan, Michael W. McDermott, Mitchel S. Berger, Michael D. Prados, Andrew T. Parsa

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

    Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma by Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer Clarke, Michael D. Prados, Shannon Chang, Mitchel S. Berger, Annissa DeSilva, Nicholas Butowski

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma

    A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma by Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

    Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts by Karine Michaud, David A. Solomon, Eric K. Oermann, Jung-Sik Kim, Wei-Zhu Zhong, Michael D. Prados, Tomoko Ozawa, C. David James, Todd Waldman

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: